The Trump administration is receiving an outpouring of support from animal advocacy groups, lawmakers and others for recent announcements to end animal testing within programs at the FDA and EPA.

For decades, scientists have leaned on the idea that animal communication is more dependent on genetics than locale. A dog is not going to learn to meow just because it’s raised around cats.

Despite mixed performance, Merck's stock has dropped 37% since mid-2024, but I maintain a buy rating due to long-term support and potential growth drivers. Merck's Q4 results beat expectations ...

Countless dirty secrets swirl around the way animals on factory farms live, but an even uglier one may be the way they sometimes die. “If everyone had to work a day in a meatpacking plant ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

When Conor Ireland picked up his cold brew at a Starbucks in London, Ontario, last month, he discovered a drawing of a sausage-shaped creature saying “neigh.” “Why is there a salamander ...

Merck MRK announced that the FDA has accepted its regulatory filing seeking approval for the subcutaneous (under the skin or SC) formulation of the blockbuster drug Keytruda (pembrolizumab).

Max Genecov is a doctoral candidate in clinical psychology at the University of Pennsylvania, a dad, and a stuffed animal owner. “I’ve always had them growing up, I had a big fantasy life with ...

Merck & Co.’s subcutaneous (SC) formulation of Keytruda has matched up to the original intravenous (IV) version on two blood concentration measurements, paving way for a potential FDA approval ...

Merck MRK is a healthcare company that manufactures pharmaceutical products to treat various conditions in many therapeutic areas, including cardiometabolic disease, cancer and infections. Don't ...

Trodelvy + Keytruda improved progression-free survival over chemo + Keytruda in PD-L1+ metastatic TNBC. No new safety signals reported in ASCENT-04; overall survival trends will be tracked with ...

Merck & Co. (MRK) releases positive phase three data for its injectable-form cancer drug Keytruda. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination to break down the ...